Clinical trial
Natalizumab Treatment of Progressive Multiple Sclerosis
NCT01077466
Study timeline
Study start (unknown)2010-03-01Date precision: month
Registry last updated2012-02-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Primary Progressive Multiple Sclerosisunresolved
Secondary Progressive Multiple Sclerosisunresolved
Interventions
NatalizumabDRUG · verified · RxNorm: natalizumab
Sponsors & collaborators
Copenhagen University Hospital, Rigshospitaletlead sponsor
Copenhagen University Hospital, Hvidovrecollaborator
Biogencollaborator
University of Copenhagencollaborator
Signifikans ApScollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01077466 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.